{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:14:53Z","timestamp":1793679293907,"version":"4.5.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12035-018-1409-x","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T16:27:39Z","timestamp":1541003259000},"page":"4751-4759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"56","author":[{"given":"Theodore D.","family":"Cosco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeer","family":"Emam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Budhdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Matthew Prina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-8675","authenticated-orcid":false,"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"issue":"1","key":"1409_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mp.2008.94","volume":"15","author":"AM Ruscio","year":"2010","unstructured":"Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010) The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 15(1):53\u201363. \n                    https:\/\/doi.org\/10.1038\/mp.2008.94","journal-title":"Mol Psychiatry"},{"key":"1409_CR2","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","author":"APA","year":"2013","unstructured":"APA (2013) Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). American Psychiatric Pub,"},{"issue":"4","key":"1409_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/13651501.2016.1207087","volume":"20","author":"B Dell'Osso","year":"2016","unstructured":"Dell'Osso B, Benatti B, Hollander E, Fineberg N, Stein DJ, Lochner C, Nicolini H, Lanzagorta N et al (2016) Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Int J Psychiatry Clin Pract 20(4):210\u2013217. \n                    https:\/\/doi.org\/10.1080\/13651501.2016.1207087","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"2","key":"1409_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1176\/ajp.146.2.246","volume":"146","author":"SE Swedo","year":"1989","unstructured":"Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, Wald ER (1989) High prevalence of obsessive-compulsive symptoms in patients with Sydenham\u2019s chorea. Am J Psychiatry 146(2):246\u2013249. \n                    https:\/\/doi.org\/10.1176\/ajp.146.2.246","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1409_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S et al (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155(2):264\u2013271. \n                    https:\/\/doi.org\/10.1176\/ajp.155.2.264","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"1409_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000356554","volume":"21","author":"AL Teixeira","year":"2014","unstructured":"Teixeira AL, Rodrigues DH, Marques AH, Miguel EC, Fontenelle LF (2014) Searching for the immune basis of obsessive-compulsive disorder. Neuroimmunomodulation 21(2\u20133):152\u2013158. \n                    https:\/\/doi.org\/10.1159\/000356554","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"1409_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4172\/2161-0665.1000113","volume":"2","author":"S Swedo","year":"2012","unstructured":"Swedo S, Leckman J, Rose N (2012) From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therapeut 2(2):113","journal-title":"Pediatr Therapeut"},{"issue":"3","key":"1409_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11920-012-0272-0","volume":"14","author":"SM Gray","year":"2012","unstructured":"Gray SM, Bloch MH (2012) Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Current psychiatry reports 14(3):220\u2013228. \n                    https:\/\/doi.org\/10.1007\/s11920-012-0272-0","journal-title":"Current psychiatry reports"},{"issue":"6","key":"1409_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.comppsych.2011.12.007","volume":"53","author":"LF Fontenelle","year":"2012","unstructured":"Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL (2012) A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 53(6):797\u2013804. \n                    https:\/\/doi.org\/10.1016\/j.comppsych.2011.12.007","journal-title":"Compr Psychiatry"},{"key":"1409_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00787-017-1099-3","volume":"27","author":"R Colak Sivri","year":"2018","unstructured":"Colak Sivri R, Bilgic A, Kilinc I (2018) Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder. Eur Child Adoles Psychiatry 27:977\u2013984. \n                    https:\/\/doi.org\/10.1007\/s00787-017-1099-3","journal-title":"Eur Child Adoles Psychiatry"},{"issue":"6","key":"1409_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","volume":"57","author":"JF Leckman","year":"2005","unstructured":"Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S et al (2005) Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette\u2019s syndrome. Biol Psychiatry 57(6):667\u2013673. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2004.12.004","journal-title":"Biol Psychiatry"},{"issue":"8","key":"1409_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.pnpbp.2010.06.028","volume":"34","author":"NG Bos-Veneman","year":"2010","unstructured":"Bos-Veneman NG, Bijzet J, Limburg PC, Minderaa RB, Kallenberg CG, Hoekstra PJ (2010) Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 34(8):1390\u20131395. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2010.06.028","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"11","key":"1409_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S0006-3223(96)00495-7","volume":"42","author":"F Brambilla","year":"1997","unstructured":"Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F (1997) Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry 42(11):976\u2013981","journal-title":"Biol Psychiatry"},{"issue":"4","key":"1409_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000026500","volume":"37","author":"P Monteleone","year":"1998","unstructured":"Monteleone P, Catapano F, Fabrazzo M, Tortorella A, Maj M (1998) Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology 37(4):182\u2013185. \n                    https:\/\/doi.org\/10.1159\/000026500","journal-title":"Neuropsychobiology"},{"issue":"7","key":"1409_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.psyneuen.2003.08.008","volume":"29","author":"D Denys","year":"2004","unstructured":"Denys D, Fluitman S, Kavelaars A, Heijnen C, Westenberg H (2004) Decreased TNF-alpha and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 29(7):945\u2013952. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2003.08.008","journal-title":"Psychoneuroendocrinology"},{"key":"1409_CR16","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 339:b2700. \n                    https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ (Clinical research ed)"},{"key":"1409_CR17","unstructured":"sant\u00e9 Omdl, Organization WH, WHO (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines, vol 1. World Health Organization,"},{"issue":"5","key":"1409_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA Kohler","year":"2017","unstructured":"Kohler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M et al (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135(5):373\u2013387. \n                    https:\/\/doi.org\/10.1111\/acps.12698","journal-title":"Acta Psychiatr Scand"},{"key":"1409_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. \n                    https:\/\/doi.org\/10.1186\/1471-2288-5-13","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"1409_CR20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","volume":"127","author":"J Lau","year":"1997","unstructured":"Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820\u2013826","journal-title":"Ann Intern Med"},{"issue":"6","key":"1409_CR21","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyn235","volume":"38","author":"NA Patsopoulos","year":"2009","unstructured":"Patsopoulos NA, Evangelou E, Ioannidis JP (2009) Heterogeneous views on heterogeneity. Int J Epidemiol 38(6):1740\u20131742. \n                    https:\/\/doi.org\/10.1093\/ije\/dyn235","journal-title":"Int J Epidemiol"},{"issue":"3","key":"1409_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"key":"1409_CR23","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (Clinical research ed) 343:d4002. \n                    https:\/\/doi.org\/10.1136\/bmj.d4002","journal-title":"BMJ (Clinical research ed)"},{"issue":"7109","key":"1409_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed) 315(7109):629\u2013634","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"1409_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000441457","volume":"85","author":"AF Carvalho","year":"2016","unstructured":"Carvalho AF, Kohler CA, Brunoni AR, Miskowiak KW, Herrmann N, Lanctot KL, Hyphantis TN, Quevedo J et al (2016) Bias in peripheral depression biomarkers. Psychother Psychosom 85(2):81\u201390. \n                    https:\/\/doi.org\/10.1159\/000441457","journal-title":"Psychother Psychosom"},{"issue":"11","key":"1409_CR26","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1017\/s0033291716000957","volume":"46","author":"AF Carvalho","year":"2016","unstructured":"Carvalho AF, Kohler CA, Fernandes BS, Quevedo J, Miskowiak KW, Brunoni AR, Machado-Vieira R, Maes M et al (2016) Bias in emerging biomarkers for bipolar disorder. Psychol Med 46(11):2287\u20132297. \n                    https:\/\/doi.org\/10.1017\/s0033291716000957","journal-title":"Psychol Med"},{"issue":"2","key":"1409_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455\u2013463","journal-title":"Biometrics"},{"issue":"11","key":"1409_CR28","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/sim.1752","volume":"23","author":"JP Higgins","year":"2004","unstructured":"Higgins JP, Thompson SG (2004) Controlling the risk of spurious findings from meta-regression. Stat Med 23(11):1663\u20131682. \n                    https:\/\/doi.org\/10.1002\/sim.1752","journal-title":"Stat Med"},{"issue":"2\u20133","key":"1409_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000119136","volume":"30","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E (1994) Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology 30(2\u20133):57\u201360. \n                    https:\/\/doi.org\/10.1159\/000119136","journal-title":"Neuropsychobiology"},{"issue":"9","key":"1409_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/0006-3223(95)00520-x","volume":"40","author":"R Weizman","year":"1996","unstructured":"Weizman R, Laor N, Barber Y, Hermesh H, Notti I, Djaldetti M, Bessler H (1996) Cytokine production in obsessive-compulsive disorder. Biol Psychiatry 40(9):908\u2013912. \n                    https:\/\/doi.org\/10.1016\/0006-3223(95)00520-x","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1409_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0165-1781(02)00233-0","volume":"112","author":"LL Carpenter","year":"2002","unstructured":"Carpenter LL, Heninger GR, McDougle CJ, Tyrka AR, Epperson CN, Price LH (2002) Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res 112(3):257\u2013262","journal-title":"Psychiatry Res"},{"key":"1409_CR32","doi-asserted-by":"publisher","first-page":"65704","DOI":"10.1155\/2007\/65704","volume":"2007","author":"N Konuk","year":"2007","unstructured":"Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S, Erdogan A (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediat Inflamm 2007:65704. \n                    https:\/\/doi.org\/10.1155\/2007\/65704","journal-title":"Mediat Inflamm"},{"issue":"2","key":"1409_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.psychres.2009.05.008","volume":"178","author":"S Fluitman","year":"2010","unstructured":"Fluitman S, Denys D, Vulink N, Schutters S, Heijnen C, Westenberg H (2010) Lipopolysaccharide-induced cytokine production in obsessive-compulsive disorder and generalized social anxiety disorder. Psychiatry Res 178(2):313\u2013316. \n                    https:\/\/doi.org\/10.1016\/j.psychres.2009.05.008","journal-title":"Psychiatry Res"},{"issue":"6","key":"1409_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.psyneuen.2009.12.005","volume":"35","author":"SB Fluitman","year":"2010","unstructured":"Fluitman SB, Denys DA, Heijnen CJ, Westenberg HG (2010) Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology 35(6):906\u2013911. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2009.12.005","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"1409_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.psychres.2015.07.009","volume":"229","author":"NP Rao","year":"2015","unstructured":"Rao NP, Venkatasubramanian G, Ravi V, Kalmady S, Cherian A, Yc JR (2015) Plasma cytokine abnormalities in drug-naive, comorbidity-free obsessive-compulsive disorder. Psychiatry Res 229(3):949\u2013952. \n                    https:\/\/doi.org\/10.1016\/j.psychres.2015.07.009","journal-title":"Psychiatry Res"},{"issue":"8","key":"1409_CR36","doi-asserted-by":"publisher","first-page":"pyw027","DOI":"10.1093\/ijnp\/pyw027","volume":"19","author":"S Simsek","year":"2016","unstructured":"Simsek S, Yuksel T, Cim A, Kaya S (2016) Serum cytokine profiles of children with obsessive-compulsive disorder shows the evidence of autoimmunity. Int J Neuropsychopharmacol 19(8):pyw027. \n                    https:\/\/doi.org\/10.1093\/ijnp\/pyw027","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"1409_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-017-1042-z","volume":"14","author":"N Rodriguez","year":"2017","unstructured":"Rodriguez N, Morer A, Gonzalez-Navarro EA, Serra-Pages C, Boloc D, Torres T, Garcia-Cerro S, Mas S et al (2017) Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. J Neuroinflammation 14(1):261. \n                    https:\/\/doi.org\/10.1186\/s12974-017-1042-z","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1409_CR38","first-page":"157","volume":"19","author":"LG Erbay","year":"2018","unstructured":"Erbay LG, Kavuran NA, Ta\u015fkapan \u00c7, Lara Utku \u0130, Yolo\u011flu S, Temelli HG, \u00dcnal S (2018) Serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-\u03b1, and IFN-\u03b3 levels in drug-free, comorbidity-free obsessive-compulsive disorder patients. ANADOLU PSIKIYATRI DERGISI-Anatolian J Psychiatry 19(2):157\u2013162","journal-title":"ANADOLU PSIKIYATRI DERGISI-Anatolian J Psychiatry"},{"key":"1409_CR39","doi-asserted-by":"publisher","unstructured":"Kohler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, de Andrade NQ, Morris G, Fernandes BS, Brunoni AR, Herrmann N, Raison CL, Miller BJ, Lanctot KL, Carvalho AF (2018) Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol 55 (5):4195\u20134206. doi:\n                    https:\/\/doi.org\/10.1007\/s12035-017-0632-1","DOI":"10.1007\/s12035-017-0632-1"},{"key":"1409_CR40","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1007\/s12035-018-1016-x","volume":"55","author":"M Maes","year":"2018","unstructured":"Maes M, Carvalho AF (2018) The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol 55:8885\u20138903. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1016-x","journal-title":"Mol Neurobiol"},{"key":"1409_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.neuropharm.2012.10.002","volume":"67","author":"FR Walker","year":"2013","unstructured":"Walker FR (2013) A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 67:304\u2013317. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2012.10.002","journal-title":"Neuropharmacology"},{"key":"1409_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pnpbp.2017.04.027","volume":"78","author":"LGP Melo de","year":"2017","unstructured":"de Melo LGP, Nunes SOV, Anderson G, Vargas HO, Barbosa DS, Galecki P, Carvalho AF, Maes M (2017) Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Prog Neuro-Psychopharmacol Biol Psychiatry 78:34\u201350. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2017.04.027","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"1409_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.resp.2013.01.013","volume":"187","author":"O Rom","year":"2013","unstructured":"Rom O, Avezov K, Aizenbud D, Reznick AZ (2013) Cigarette smoking and inflammation revisited. Respir Physiol Neurobiol 187(1):5\u201310. \n                    https:\/\/doi.org\/10.1016\/j.resp.2013.01.013","journal-title":"Respir Physiol Neurobiol"},{"issue":"1","key":"1409_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/physrev.00039.2016","volume":"98","author":"R Dantzer","year":"2018","unstructured":"Dantzer R (2018) Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev 98(1):477\u2013504. \n                    https:\/\/doi.org\/10.1152\/physrev.00039.2016","journal-title":"Physiol Rev"},{"issue":"8","key":"1409_CR45","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","volume":"74","author":"S Attwells","year":"2017","unstructured":"Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA et al (2017) Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA psychiatry 74(8):833\u2013840. \n                    https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.1567","journal-title":"JAMA psychiatry"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1409-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1409-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1409-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T12:24:18Z","timestamp":1576499058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1409-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1409-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"16 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"DJS is supported by the Medical Research Council of South Africa and has received research grants and\/or consultancy honoraria from Abbott, Astrazeneca, Eli-Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Takeda, Tikvah, and Wyeth. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}